Abstract:Background The extravascular (EV) implantable cardioverter-defibrillator (ICD) includes features to address sensing and arrhythmia detection challenges presented by its substernal lead location. Objectives In this study, the authors sought to evaluate sensing and detection performance in 299 patients discharged with an EV-ICD in the global pivotal study. Methods We reviewed and adjudicated all induced ventricular fibrillation (VF) episodes and spontaneous device-stored episodes that satisfied rate and duration criteria in a programmed ventricular tachycardia (VT)/VF therapy zone. Results At implantation, all EV-ICDs detected induced VF at the programmed sensitivity; 95.9% detected VF with a 3× safety margin. In follow-up, EV-ICDs detected all 59 VT/VF episodes that sustained until therapy. Of 1,034 non-VT/VF episodes, oversensing caused 87.9% and supraventricular tachycardia caused 12.1%. Therapy was withheld in 80.9%, aborted in 10.6%, and delivered in 8.5%. The most common causes of oversensing were myopotentials (61.2%) and P-wave oversensing (PWOS) (19.9%). Inappropriate shocks occurred in only 3.2% of myopotential episodes, but in 21.8% of PWOS episodes. Myopotential oversensing was more common with Ring-Can sensing ( P < 0.0001) and correlated with low R-wave amplitude ( P < 0.0001). PWOS occurred almost exclusively with Ring1-Ring2 sensing ( P = 0.0001) and began with transient decrease in R-wave or increase in P-wave amplitude ( P < 0.0001). In software emulation, a new PWOS discriminator significantly reduced total inappropriate detections. Conclusions In a global population, EV-ICD detected induced and spontaneous VT/VF accurately. Although discriminators withheld detection from most non-VT/VF episodes, inappropriate shocks were common. The most common cause was PWOS, which may be reduced by optimizing sensing at implantation and incorporation of the PWOS discriminator, which is now in the current device. (Extravascular ICD Pivotal Study [EV ICD]; NCT04060680 )

Incidence and Causes of Inappropriate Detection and Therapy by Implantable Defibrillators of Cardioversion in Patients with Ventricular Tachyarrhythmia

Analysis of causes of inappropriate discharge of an implantable cardioverter defibrillator in elderly patients

Cause and Treatment of Inappropriate Therapy of Implantable Cardioverter Defibrillators

The occurrence characteristics and optimal management of inappropriate shocks in patients with implantable cardioverter defibrillator

T wave sensing test during ICD implantation procedure in inherited arrhythmias patients

Retrospective Analysis of the Appropriate and Inappropriate Shock Characteristics in 134 Patients with Implantable Cardioverter-Defibrillator

Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death: a single center experience

Multivariable analysis of incident ventricular tachycardia or ventricular fibrillation in patients with implantable cardioverter defibrillator

Association Between Atrial Fibrillation and Appropriate Implantable Cardioverter Defibrillator Therapy: Results from A Prospective Study

Clinical application of implantable cardioverter defibillators and follow-up of patients received cardioverter defibrillators implantation

Extravascular Implantable Cardioverter-Defibrillator Sensing and Detection in a Large Global Population

Prognosis in patients with coronary heart disease and ventricular arrhythmias received implantable cardioverter defibrillators

Inappropriate therapies in modern implantable cardioverter-defibrillators: A propensity score-matched comparison between single- and dual-chamber discriminators in single-chamber devices THe sINGle lead Study (THINGS Study)

[The Prospective Study on the Prognosis in Patients with Ventricular Tachycardia or Fibrillation Treated with Implantable Automatic Cardioverter Defibrillator].

Appropriate and Inappropriate ICD Shocks in Patients with LVADS: Prevalence, Associated Factors, and Etiologies

Follow up of patients with implantable cardioverter defibrillator.

CLINICAL APPLICATION OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

Evaluation of the efficacy of implantable cardioverter defibrillators for the treatment of fatal ventricular arrhythmia

Efficacy and Safety of Implantable Cardioverter Defibrillatoravoiding Routine Defibrillation Threshold Testing

Progress in the Studies of Inappropriate Shocks of Implantable Cardioverter-Defibrillator

Inappropriate Shocks With Subcutaneous Implantable Cardioverter-Defibrillator in a Young Patient: A Case Report